25,243 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Eagle Asset Management Inc.

Eagle Asset Management Inc. acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 25,243 shares of the medical device company’s stock, valued at approximately $2,619,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Citizens Financial Group Inc. RI raised its position in Cooper Companies by 11.7% during the third quarter. Citizens Financial Group Inc. RI now owns 6,588 shares of the medical device company’s stock valued at $727,000 after purchasing an additional 688 shares in the last quarter. Advisors Asset Management Inc. increased its stake in shares of Cooper Companies by 24.6% in the 3rd quarter. Advisors Asset Management Inc. now owns 34,639 shares of the medical device company’s stock valued at $3,822,000 after purchasing an additional 6,839 shares during the last quarter. Segall Bryant & Hamill LLC raised its holdings in shares of Cooper Companies by 21.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 106,421 shares of the medical device company’s stock worth $11,742,000 after buying an additional 18,839 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Cooper Companies during the 3rd quarter worth $1,154,000. Finally, Tranquility Partners LLC lifted its position in shares of Cooper Companies by 7.1% during the 3rd quarter. Tranquility Partners LLC now owns 9,341 shares of the medical device company’s stock worth $1,031,000 after buying an additional 620 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 1.6 %

Shares of NASDAQ:COO opened at $102.40 on Tuesday. The firm has a market cap of $20.39 billion, a P/E ratio of 57.05, a P/E/G ratio of 2.17 and a beta of 0.99. The Cooper Companies, Inc. has a 12-month low of $82.21 and a 12-month high of $112.38. The business has a fifty day simple moving average of $105.74 and a 200 day simple moving average of $98.39. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $997.30 million. During the same period last year, the company earned $0.84 earnings per share. The firm’s revenue was up 7.8% compared to the same quarter last year. Analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Insider Transactions at Cooper Companies

In other news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This trade represents a 72.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Brian G. Andrews sold 24,788 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the sale, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The trade was a 78.94 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 256,373 shares of company stock worth $27,637,427. Company insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Wells Fargo & Company boosted their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, November 20th. Morgan Stanley raised their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 10th. Robert W. Baird upped their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.